CDT Equity Inc. (CDTTW)Naples, United States | NasdaqCM
0.01 USD
0.00
(-26.174%) ⇩
(July 13, 2026, 2:17 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 3:46 a.m. EDT
The security is trading at a floor level of $0.01, having failed to generate any meaningful price appreciation over the trailing period, which suggests a lack of market confidence in its immediate prospects. The fundamental picture is severely compromised by a negative book value of -$77.82 and a current ratio of only 0.34, indicating significant liquidity stress and insolvency risks that outweigh any reported free cash flow. There is no dividend income to provide a safety net, and the absence of historical price data prevents any assessment of long-term business quality or growth trajectory. Combined with a beta of 1.46, the stock exhibits high volatility without the underlying earnings power to support such movement, making it a speculative trap rather than an investment opportunity. |
| Attribute | Value |
|---|---|
| Beta | 1.46 |
| Previous Name | Conduit Pharmaceuticals Inc. |
| Website | https://www.cdtequity.com |
| Attribute | Value |
|---|---|
| Address1 | 4,581 Tamiami Trail North |
| Address2 | Suite 200 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.457 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | -77.816 |
| City | Naples |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.011 |
| Current Ratio | 0.342 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.011 |
| Day Low | 0.011 |
| Display Name | CDT Equity |
| Ebitda | -24,738,000 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.011 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.011 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.011 - 0.011 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,783,690,200,000 |
| Float Shares | 2,259,990 |
| Free Cashflow | 5,220,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 4 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Language | en-US |
| Long Business Summary | CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida. |
| Long Name | CDT Equity Inc. |
| Market | us_market |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1772079937 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -39,224,000 |
| Open | 0.0119 |
| Operating Cashflow | -15,555,000 |
| Operating Margins | 0.0 |
| Phone | 646 491 9132 |
| Prev Name | Conduit Pharmaceuticals Inc. |
| Previous Close | 0.0149 |
| Price Hint | 4 |
| Price To Book | -0.0001413591 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.118 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0039 |
| Regular Market Change Percent | -26.174498 |
| Regular Market Day High | 0.011 |
| Regular Market Day Low | 0.011 |
| Regular Market Day Range | 0.011 - 0.011 |
| Regular Market Open | 0.0119 |
| Regular Market Previous Close | 0.0149 |
| Regular Market Price | 0.011 |
| Regular Market Time | 1,783,966,666 |
| Regular Market Volume | 1,021 |
| Return On Assets | -3.4495301 |
| Sand P52 Week Change | 0.20847368 |
| Sector | |
| Sector Key | |
| Source Interval | 15 |
| State | FL |
| Symbol | CDTTW |
| Total Cash | 1,509,000 |
| Total Cash Per Share | 0.311 |
| Total Debt | 775,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 1,021 |
| Website | https://www.cdtequity.com |
| Zip | 34,103 |